{"id": "1355472589754298370", "creation": 1612004823.0, "user_id": "65890224", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 1, "like_count": 1, "quote_count": 0}}, "text": "#Novavax #COVID19 #Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial - First to Demonstrate Clinical Efficacy Against COVID-19 and Both UK and South Africa #Variants. Strong efficacy in Phase 3 UK trial with over 50% of cases attributable to the now\u2026https://t.co/wPxfCeHJHn", "first_save": 1634559108.199414, "hashtags": ["#NOVAVAX", "#COVID19", "#VACCINE", "#VARIANTS"]}